Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarci
- This topic has 0 replies, 1 voice, and was last updated 3 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis
https://www.nature.com/articles/s41418-020-0505-4
Thanks to Springer for this piece.
Gavin
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.